IMPDH2 and osteosarcoma: As IMPDH2 overexpression is frequently observed in osteosarcoma patients with poor response to chemotherapy, targeting of IMPDH2 by RNAi or more effective inhibitors in combination with chemotherapy might provide an effective synergistic treatment to overcome chemoresistance in osteosarcomas.